Friday , 1 November 2024

Base

and the Winner of the DE-flation/IN-flation Battle is About to Be….?

Many investors are positioning their portfolios based upon their opinions as to whether or not we will encounter IN-flation or DE-flation. Well, what the MS Commodity Index (CRX) does over the next few weeks might tell us a good deal about how to best position one's portfolio. Take a look at the latest CRX graph below for an indication.

Read More »

A Massive Stock Market Crash Is Coming! (+2K Views)

In the financial world, the month of October is synonymous with stock market crashes. So will a massive stock market crash happen this year? You never know. Hopefully we'll get through October (and the rest of this year) but, without a doubt, one is coming at some point. The truth of the matter is that our financial system is even more vulnerable than it was back in 2008 and, as such, many financial experts are warning that the next crash is rapidly approaching and that those on the wrong end of the coming crash are going to be absolutely wiped out. Let’s take a look at some of the financial experts that are predicting really bad things for our financial markets in the months ahead. Words: 1634

Read More »

These Degrees Are the Ticket to the 10 Top Paying Careers

Staying in school has always been seen as the way to get ahead. Post-secondary education, especially a university degree, is often the ticket to the big pay cheque but not all degrees are created equally when it comes to earning potential. Which programs lead to the best paying jobs? Check out our list of the top earning degrees. Words: 775

Read More »

Transition Therapeutics Inc: On Course to Alleviate Effects of Alzheimer’s Disease, Bipolar Disorder & Type 2 Diabetes?

Transition Therapeutics Inc. (TSX:TTH/NASDAQ:TTHI) is in the process of developing an oral drug that has the potential to address both neuropsychiatric changes and cognitive declines associated with Alzheimer's Disease (AD) and stabilize the mood swings of those suffering from Bipolar Disorder (BPD) as well as a drug that plays a role in regulating obesity in those genetically predisposed to Type 2 Diabetes (DM11). With millions of people suffering from such health issues, and costing society billions of dollars in the treatment of same, such new drugs would be most welcome on all fronts. We wish Transition Therapeutics success in their endeavours and hope the development of each of their products come to fruition in rapid fashion. Here is their story to help you decide if its stock should be in your portfolio. Words: 1050

Read More »